Community Health Systems, Inc.
Rank #12ValueCYH · NYSE · Healthcare
Community Health Systems, Inc. (CYH) — Rank #12 by gross profitability (GP/assets 0.87) · ROE -36.6% · Piotroski F-Score 8 / 9.
As-of 2026-09-15 · CIK 0001108109 · all metrics point-in-time as of the filing date.
About
Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States.
Show moreShow less
The company offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. It also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, and direct-to-consumer virtual health visits. Community Health Systems, Inc.
was founded in 1985 and is headquartered in Franklin, Tennessee.
- Industry
- Medical Care Facilities
- Sector
- Healthcare
- State
- DE
- Filer Category
- Accelerated filer
- Fiscal Year End
- December 31
- Website
- chs.net
Price History
Company Snapshot
P/E and dividend yield are the primary valuation lenses for mature businesses.
Market Cap
$410.32M
P/E (annual)
0.8
P/S (annual)
0.0
P/B
—
P/OCF (annual)
0.8
Shareholder Yield
-2.2%
Employees
44,000
Industry
Medical Care Facilities
Exchange
NYSE
Signal Flags
Quality Profile
Profitability
1/1 passSafety
1/1 passCash Flow
2/3 passGrowth
0/2 passTerry Smith quality gate
Passes 1/5 Terry Smith thresholds1 of 5 threshold not computable from filed data.
What Growth Is Priced In
Implied revenue growth (10Y)
-29.9%
The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).
Dilution drag: 2.2% — per-share value needs a total required return of -27.7% once share-count change is priced in.
vs. own 6-year median revenue growth: -0.0%
Cost-of-equity sensitivity (implied growth at different discount rates)
r = 8%
-31.8%
r = 10% (base)
-29.9%
r = 12%
-28.2%
Net debt / market cap: 2393.4%— material leverage inflates the implied growth read.
Valuation History
Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.
P / E
Price / diluted EPS
P / S
Price / revenue per share
P / GP
Price / gross profit per share
P / FCF
Price / free cash flow per share
Earnings bubble check
Current margins may be above sustainable levels — a P/E based on peak earnings can overstate cheapness.
Dividend yield and payout ratio are the primary reads at this stage (trailing P/E — see valuation above).
Profitability
Gross profitability (GP / assets)
0.87
Primary signal (Novy-Marx).
1st of 8 SIC 80 peers
Return on equity
-36.6%
Gross margin
85.1%
1st of 8 SIC 80 peers
Revenue growth (YoY)
-1.2%
Gross margin improving
Margin trend vs prior year.
Operating Leverage
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue vs COGS | ||||
| Revenue vs OpEx | ||||
| Op. Income vs Revenue |
Growth
Revenue CAGR (3Y)
0.7%
Revenue CAGR (5Y)
1.2%
Earnings CAGR (3Y)
122.8%
FCF CAGR (3Y)
—
Anti-fragile safety
Balance-sheet safety
Composite anti-fragile check.
Debt / equity
—
Current ratio
1.53×
7th of 8 SIC 80 peers
Quick ratio
1.14×
Net cash
-$9.40B
Cash & equivalents minus total debt.
Cash-flow health
Free cash flow
$208.00M
Operating cash flow minus capex.
Positive free cash flow
FCF / net income
-0.59
Cash-backing of earnings.
FCF/NI divergence
Unfavorable divergence (yellow flag).
Accruals healthy
Cash-backed earnings.
SBC / revenue
0.1%
Stock-based comp intensity.
Piotroski F-Score
F-Score
8 / 9
Fundamental-strength score (0-9).